Published in JAMA on May 03, 1985
A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc Natl Acad Sci U S A (1990) 3.76
Toxic shock syndrome-associated staphylococcal and streptococcal pyrogenic toxins are potent inducers of tumor necrosis factor production. Infect Immun (1989) 2.77
Steady-state staphylococcal enterotoxin type C mRNA is affected by a product of the accessory gene regulator (agr) and by glucose. Infect Immun (1991) 2.25
Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun (1998) 2.22
A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13
Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus. J Clin Microbiol (1990) 1.54
Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome. J Clin Microbiol (1986) 1.42
Competitive, enzyme-linked immunosorbent assay for toxic shock syndrome toxin 1. J Clin Microbiol (1985) 1.41
Toxic shock syndrome. Clin Microbiol Rev (1988) 1.37
Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun (1988) 1.36
Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody. Infect Immun (1990) 1.31
Staphylococcal enterotoxin A gene (sea) expression is not affected by the accessory gene regulator (agr). Infect Immun (1993) 1.23
Colony immunoblot assay for the detection of staphylococcal toxic shock syndrome toxin 1 (TSST-1) with anti-TSST-1 F(ab')2 fragments. J Clin Microbiol (1989) 1.23
Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1. Infect Immun (1989) 1.14
Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome. Infect Immun (1986) 1.06
Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits. Infect Immun (1986) 1.05
Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome. J Clin Microbiol (1988) 1.04
Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A. Infect Immun (1990) 1.00
Production and characterization of monoclonal antibodies to toxic shock syndrome toxin 1 and use of a monoclonal antibody in a rapid, one-step enzyme-linked immunosorbent assay for detection of picogram quantities of toxic shock syndrome toxin 1. J Clin Microbiol (1987) 1.00
Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells. Clin Exp Immunol (1989) 0.97
Protection of rabbits in an infection model of toxic shock syndrome (TSS) by a TSS toxin-1-specific monoclonal antibody. Infect Immun (1988) 0.96
Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines. Infect Immun (1996) 0.95
Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect Dis (2010) 0.93
Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci. J Clin Microbiol (1987) 0.91
Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk. Appl Environ Microbiol (1991) 0.91
Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus. Infect Immun (1989) 0.90
Hormonal influence on experimental infections by a toxic shock strain of Staphylococcus aureus. Infect Immun (1986) 0.82
Production of tumour necrosis factors by human T cells stimulated by a superantigen, toxic shock syndrome toxin-1. Clin Exp Immunol (1994) 0.81
Identification of a bacteriophage containing a silent staphylococcal variant enterotoxin gene (sezA+). Infect Immun (1990) 0.81
Purification and partial characterization of a product from Yersinia pseudotuberculosis with the ability to activate human T cells. Infect Immun (1993) 0.77
Non-menstrual associated toxic shock syndrome. Ulster Med J (1987) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Epidemic listeriosis--evidence for transmission by food. N Engl J Med (1983) 11.72
Demonstration of the agent of Legionnaires' disease in tissue. N Engl J Med (1977) 8.50
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
Listeriosis. JAMA (1989) 7.06
The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit. Ann Intern Med (1982) 6.62
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med (2000) 6.58
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis (1983) 6.15
Developing a Housing Program in a Southern City. Am J Public Health Nations Health (1937) 5.74
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
Neisseria gonorrhoeae: experimental infection of laboratory animals. Science (1972) 5.49
Epidemiology of human listeriosis. Clin Microbiol Rev (1991) 5.21
Public health policy for preventing violence. Health Aff (Millwood) (1993) 5.17
Clinical algorithm for treatment of Plasmodium falciparum malaria in children. Lancet (1996) 5.07
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
An outbreak of gastroenteritis and fever due to Listeria monocytogenes in milk. N Engl J Med (1997) 4.33
The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992-1993: results of population-based laboratory active surveillance. Clin Infect Dis (1998) 4.33
Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet (1992) 4.32
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness. J Infect Dis (1984) 3.81
Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994) J Clin Endocrinol Metab (1998) 3.69
An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis (1997) 3.39
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA (1993) 3.31
Predicting Mycobacterium avium complex bacteremia in patients infected with human immunodeficiency virus: a prospectively validated model. Clin Infect Dis (1994) 3.30
Legionnaires' disease outbreak at an Atlanta, Georgia, Country Club: evidence for spread from an evaporative condenser. Am J Epidemiol (1980) 3.30
Water-related nosocomial pneumonia caused by Legionella pneumophila serogroups 1 and 10. J Infect Dis (1985) 3.16
Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann Intern Med (1982) 3.12
Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet (1982) 3.10
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Intercontinental spread of an epidemic group A Neisseria meningitidis strain. Lancet (1989) 3.09
The carrier state: Neisseria meningitidis. J Antimicrob Chemother (1986) 3.00
The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi. Am J Trop Med Hyg (1996) 2.94
Analysis of clinical and food-borne isolates of Listeria monocytogenes in the United States by multilocus enzyme electrophoresis and application of the method to epidemiologic investigations. Appl Environ Microbiol (1990) 2.90
Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA (1985) 2.87
Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med (2000) 2.85
Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med (1980) 2.85
Role of foods in sporadic listeriosis. I. Case-control study of dietary risk factors. The Listeria Study Group. JAMA (1992) 2.82
Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group. J Infect Dis (1990) 2.80
Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. JAMA (1990) 2.79
Risk factors for group B streptococcal disease in adults. Ann Intern Med (1995) 2.78
"Endotoxicity" of the Legionnaires' disease bacterium. Ann Intern Med (1979) 2.78
Immunochemical, serologic, and immunologic properties of major antigens isolated from the Legionnaires' disease bacterium. Observations bearing on the feasibility of a vaccine. Ann Intern Med (1979) 2.76
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann Intern Med (1996) 2.65
Seroepidemiology and chemoprophylaxis disease due to sulfonamide-resistant Neisseria meningitidis in a civillian population. J Infect Dis (1974) 2.64
Implantation and use of a subcutaneous culture chamber in laboratory animals. Lab Anim Sci (1973) 2.60
Validation of Legionella pneumophila indirect immunofluorescence assay with epidemic sera. J Clin Microbiol (1981) 2.56
Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med (2000) 2.51
Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection. J Infect Dis (1974) 2.48
Investigation of an outbreak of listeriosis: new hypotheses for the etiology of epidemic Listeria monocytogenes infections. J Infect Dis (1989) 2.42
Association of sporadic listeriosis with consumption of uncooked hot dogs and undercooked chicken. Lancet (1988) 2.42
Infections with Mycobacterium chelonei in patients receiving dialysis and using processed hemodialyzers. J Infect Dis (1985) 2.39
Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet (1985) 2.39
A new Legionella species, Legionella feeleii species nova, causes Pontiac fever in an automobile plant. Ann Intern Med (1984) 2.35
The changing epidemiology of acquired drug-resistant tuberculosis in San Francisco, USA. Lancet (1996) 2.35
Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. Am J Trop Med Hyg (1996) 2.34
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia. Am J Trop Med Hyg (1998) 2.33
Acinetobacter calcoaceticus: a nosocomial pathogen with an unusual seasonal pattern. J Infect Dis (1979) 2.31
Reactivity of serum from patients with suspected legionellosis against 29 antigens of legionellaceae and Legionella-like organisms by indirect immunofluorescence assay. J Infect Dis (1983) 2.28
Experimental pinta in the chimpanzee. JAMA (1968) 2.27
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Human T-cell mitogen-activated protein kinase kinases are related to yeast signal transduction kinases. J Biol Chem (1992) 2.23
Possible nosocomial transmission of group B streptococci in a newborn nursery. J Pediatr (1975) 2.21
An outbreak of Escherichia coli O157:H7 infections associated with leaf lettuce consumption. J Infect Dis (1998) 2.18
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int J Syst Bacteriol (1996) 2.18
Identification of problem Neisseria gonorrhoeae cultures by standard and experimental tests. J Clin Microbiol (1982) 2.17
Role of foods in sporadic listeriosis. II. Microbiologic and epidemiologic investigation. The Listeria Study Group. JAMA (1992) 2.15
Toxic shock syndrome surveillance in the United States, 1980 to 1981. Ann Intern Med (1982) 2.14
Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med (1993) 2.14
Legionnaires' disease. Pathological and historical aspects of a 'new' disease. Arch Pathol Lab Med (1978) 2.13
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Global epidemiology of meningococcal disease. Clin Microbiol Rev (1989) 2.11
Long-term malaria prophylaxis with weekly mefloquine. Lancet (1993) 2.09
Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group. J Clin Microbiol (1996) 2.08
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Comparative efficacy of ceftriaxone and rifampicin in eradicating pharyngeal carriage of group A Neisseria meningitidis. Lancet (1988) 2.06
Group A meningococcal carriage in travelers returning from Saudi Arabia. JAMA (1988) 2.06
Pathologic findings in guinea pigs inoculated intraperitoneally with the Legionnaires' disease bacterium. Ann Intern Med (1979) 2.05
Evaluation of darkfield and immunofluorescent techniques for demonstrating Treponema pallidum in fluids with small numbers of organisms. Br J Vener Dis (1969) 2.04